Citation Tools

0419: A Prospective Phase I/Ii Trial of the Cyclooxyge-Nase-2 Inhibitor Celecoxib in Patients with Carcinoma of the Cervix with Biomarker Assessment of the Tumor Micro Environment

Download to a citation manager

Cite this article as:
Herrera FG, Chan P, Doll C, et al
0419: A Prospective Phase I/Ii Trial of the Cyclooxyge-Nase-2 Inhibitor Celecoxib in Patients with Carcinoma of the Cervix with Biomarker Assessment of the Tumor Micro Environment